Japan grants Orphan Drug Designation to Lundbeck's potential treatment for Multiple System Atrophy

The Ministry of Health, Labour, and Welfare (MHLW) in Japan has granted Orphan Drug Designation (ODD) to Lundb...

March 11, 2025 | Tuesday | News
CEPI funds Nagasaki University’s ‘Nanoball’ technology to help defeat Disease X

A new ‘nanoball’ vaccine platform developed by experts in Japan will be tested as part of new research, supp...

March 10, 2025 | Monday | News
Shimadzu announces launch of two models of Scanning Electron Microscope SUPERSCAN SS-4000

Shimadzu Corporation has launched two models of the scanning electron microscope “SUPERSCAN SS-4000” within ...

March 10, 2025 | Monday | News
Indaptus Therapeutics extends patent portfolio in China, Japan, and Israel

US-based biotech firm Indaptus Therapeutics, Inc. has secured new patent approvals in China, Japan and Israel for its De...

March 7, 2025 | Friday | News
Astellas and Yaskawa to establish joint venture in Japan focused on cell therapy manufacturing

Japan-headquartered Astellas Pharma Inc. and Yaskawa Electric Corporation have signed a definitive agreement t...

March 6, 2025 | Thursday | News
Olympus to launch single-use hemostasis clip in US, with plans for global expansion

Japan-headquartered Olympus, a global medical technology company committed to making people's lives healthier, safer and...

March 5, 2025 | Wednesday | News
Japan's Shionogi inks agreement with Osaka Metropolitan University to establish model for city resilient to infectious diseases

Japan-based Shionogi & Co. has announced the conclusion of a comprehensive collaboration agreement with Osaka Metrop...

March 4, 2025 | Tuesday | News
“Personalised medicine is now a reality, not just an aspiration”

Can you share how the company’s focus has evolved since its founding, and what areas are central to Terumo's curre...

March 1, 2025 | Saturday | Opinion
WuXi Biologics Successfully Passes Japan PMDA GMP Inspection Again

WuXi Biologics, a leading global contract research, development, and manufacturing organization (CRDMO...

February 28, 2025 | Friday | News
Eisai grants exclusive development and distribution rights for Tasurgratinib in Greater China to SciClone Pharma

Japan-headquartered pharmaceutical firm Eisai has entered into an exclusive license agreement with a subsidiary of SciCl...

February 28, 2025 | Friday | News
CSL receives approval for ANDEMBRY in Japan to prevent hereditary angioedema

CSL Behring K.K. has received manufacturing and marketing approval from Japan's Ministry of Health, Labou...

February 21, 2025 | Friday | News
Japan's NEC invests in Aetion, US-based provider of healthcare analytics platforms

NEC Orchestrating Future Fund, an ecosystem-based corporate venture capital (CVC) fund, has invested in Aetion, Inc., a ...

February 19, 2025 | Wednesday | News
Japan builds machine learning model to predict amyloid beta accumulation in brain

Oita University and Eisai Co., in Japan, have announced the development of a machine learning model to predict amyloid b...

February 17, 2025 | Monday | News
Takeda Reports Strong Q4 2024 Performance with 9.8% Revenue Growth, Driven by Oncology and Plasma-Derived Therapies

Takeda Pharmaceuticals has released its financial report for the fourth quarter of 2024, showcasing strong financial per...

February 17, 2025 | Monday | Company results
TriNetX and Fujitsu launch JV to increase Japanese patients' access to life-changing medicines

TriNetX, a global leader in real-world data (RWD) and real-world evidence (RWE) solutions, has partnered with Fujitsu, a...

February 13, 2025 | Thursday | News
Yokogawa Launches OpreX™ Quality Management System to Enhance Quality Assurance

Yokogawa Electric Corporation announced the launch of the OpreX™ Quality Management System, a cutting-edge, cloud-...

February 11, 2025 | Tuesday | News
Japan's PHC partners with CCRM in Canada to develop primary T-cell expansion culture processes

Japan-based PHC Corporation has signed a Master Collaboration Agreement with CCRM (based in Canada) to work together on ...

February 10, 2025 | Monday | News
Bain Capital to acquire Mitsubishi Tanabe Pharma Corporation for $3.3 B

Bain Capital, a leading global private investment firm, has signed a definitive agreement to acquire Mitsubishi Tanabe P...

February 6, 2025 | Thursday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls